Hiofu and BPI partner to bring verified skills infrastructure to Barbados’ pharmaceutical sector, strengthening workforce visibility and supporting regional manufacturing growth.

Share post
Hiofu and BPI partner to bring verified skills infrastructure to Barbados’ pharmaceutical sector, strengthening workforce visibility and supporting regional manufacturing growth.
Hiofu and BPI are partnering to bring verified skills infrastructure to Barbados’ emerging pharmaceutical manufacturing sector. The initiative will give BPI greater visibility of the region’s pharmaceutical talent while helping prospective manufacturers and investors understand the workforce capabilities available to support operations at scale.
LONDON, United Kingdom and BRIDGETOWN, Barbados, 25 August 2026. Hiofu Limited, a capability-first infrastructure platform for the future of hiring, and Barbados Pharmaceutical Inc. (BPI) have signed a strategic partnership to bring verified skills infrastructure to Barbados' emerging pharmaceutical manufacturing sector, with the potential to scale the model across the Caribbean.
Under this partnership, BPI will integrate Hiofu's HSP1 Verified Skills Passport, a portable, evidence-backed record of a candidate’s verified capabilities, into its own recruitment, while building a clearer picture of pharmaceutical, quality, engineering and technical talent across Barbados and the wider Caribbean, including where further workforce development is needed. Rather than relying solely on self-reported qualifications, HSP1 enables prospective employees to demonstrate what they can actually do and integrates directly into existing hiring workflows without requiring employers to replace their current systems.
"We built HSP1 because the way people demonstrate professional value needs to change," said Eva M-Harrison, Chief Executive Officer of Hiofu. "Proof beats promise. We're excited to bring that thinking to the BPI ecosystem and to the talent they serve across the pharmaceutical sector."
"One of the first questions we hear from manufacturers and investors is, ‘Where is the skilled workforce?" said Cindi Lewis, Chief Executive Officer of BPI. "This partnership helps us answer that with evidence, giving prospective partners a clearer view of the capabilities that already exist in Barbados and across the region."
The partnership reflects an innovative global paradigm shift in how employers verify talent. Employers face growing pressure to assess capability more directly in an increasingly skills-based labour market. As AI-generated CVs and other claims-based hiring tools make it easier to present qualifications and experience without clear evidence of capability, Hiofu's infrastructure is designed to make that evidence available at the point of application.
For BPI, workforce readiness forms part of the wider infrastructure required to establish a competitive pharmaceutical manufacturing sector. Alongside manufacturing capacity, regulatory systems, investment and regional market access, the ability to identify and demonstrate available skills is critical to giving prospective manufacturers confidence that operations can be established and scaled in Barbados and the Caribbean.
Hiofu is building the capability-first infrastructure for the future of hiring, so individuals can show what they can do, at the point where it matters most. Its flagship product, HSP1, is a verified, candidate-owned skills passport that integrates into existing hiring systems as a layer, underpinning the primary data that goes into hiring decisions. Hiofu's vision is a future where every person's capability is verifiable, visible, and portable across locations, becoming the infrastructure the world of work runs on. Learn more at hiofu.com.
Barbados Pharmaceutical Inc. (BPI) is an entity of the Government of Barbados working to build pharmaceutical manufacturing capacity in Barbados and strengthen regional health and supply chain resilience. BPI attracts investment, develops manufacturing partnerships, and advances the infrastructure required for local pharmaceutical production, connecting Barbados and the Caribbean with partners across Africa, Latin America, Europe, and the wider Global South. Learn more at barbadospharmainc.com.
Media Contact
Hiofu Limited: Eva M-Harrison, Chief Executive Officer, emh@hiofu.com
Barbados Pharmaceutical Inc. (BPI): Dr Cindi Lewis, Chief Executive Officer Ag, cindi@barbadospharmainc.org

BPI and AMA Medical Manufacturing are advancing a joint venture to build an IV fluids facility at the Grantley Adams Industrial Estate, with project preparation launching in fall 2026.

BPI and Nigeria's PVAC signed a Memorandum of Understanding in Abuja on November 25, establishing a framework for pharmaceutical cooperation across manufacturing, regulation, workforce and market access.